Partner Liane Peterson will present “Assessing Secondary Considerations in Light of Blocking Patents Post-Acorda” at the American Conference Institute’s (ACI) Paragraph IV Disputes Conference on Tuesday, April 30, 2019 in New York, New York.
Topics Peterson and the other panelists will cover include:
- Reviewing the expanding doctrine of blocking patents relative to secondary considerations
- Exploring the difficulty of presenting evidence of “negative acts”
- Considering which party bears the burden of proving the effect of the putative blocking patent
- Determining how much proof is required to overcome the “solid premise of diminished incentive” when a blocking patent is invoked?
- Analyzing how the Acorda decision effects the obviousness analysis
For more information and to register, please visit ACI’s website.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.